Glioma and Melanoma Cell Treatment
Corresponding Organization :
Other organizations : Karolinska University Hospital, Karolinska Institutet, Krankenhaus Nordwest
Variable analysis
- Decitabine treatment at 1 µM
- Growth/survival of DBTRG05-MG, SNB19, and M624 tumor cell lines
- Cell culture medium: RPMI 1640 with L-glutamine (2 mM), antibiotics (penicillin, 100 IU/mL, and streptomycin, 100 µg/mL), and 10% FBS
- Cell lines: DBTRG05-MG, SNB19, and M624 tumor cell lines
- Positive control: Not specified
- Negative control: Not specified
Annotations
Based on most similar protocols
As authors may omit details in methods from publication, our AI will look for missing critical information across the 5 most similar protocols.
About PubCompare
Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.
We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.
However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.
Ready to get started?
Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required
Revolutionizing how scientists
search and build protocols!